Developing recombinant antibodies for biomarker detection.

Area of Science:

• Biotechnology
• Immunology
• Molecular Biology

Background:

• Monoclonal antibodies (mAbs) are crucial for biomarker validation and diagnostic assays.
• Traditional hybridoma technology for mAb production is time-consuming and may not yield desired antibodies.

Purpose of the Study:

• To recommend an improved process flow for affinity reagent production using combinatorial protein display systems.
• To highlight the advantages of these systems over hybridomas for generating high-affinity mAbs.

Main Methods:

• Utilizing combinatorial protein display systems (yeast or phage display) for antibody fragment selection.
• Employing directed molecular evolution (DME) for affinity maturation and optimization of antibodies.
• Using recombinant libraries from immunizations or non-immune sources.

Main Results:

• Combinatorial display systems can rapidly produce high-affinity antibodies (<10 nM).
• Non-immune libraries offer an alternative when immunization is not feasible.
• DME effectively optimizes antibody affinity and can be applied to both display-derived and hybridoma-derived mAbs.
• Combinatorial display facilitates the identification of antibody pairs for sandwich assays.

Conclusions:

• Combinatorial protein display systems provide a more efficient and versatile approach to monoclonal antibody production.
• Directed molecular evolution is a key component for optimizing antibody reagents for specific applications.
• These advanced methods accelerate the development of critical reagents for diagnostics and research.